Literature DB >> 28762389

Incontinence: Patients prefer combination therapy.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28762389     DOI： 10.1038/nrurol.2017.129

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients.

Authors:  Dudley Robinson; Con Kelleher; David Staskin; Elizabeth R Mueller; Christian Falconer; Jianye Wang; Arwin Ridder; Matthias Stoelzel; Asha Paireddy; Rob van Maanen; Zalmai Hakimi; Sender Herschorn
Journal:  Neurourol Urodyn       Date:  2017-07-13       Impact factor: 2.696
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.